Thank you for your post @RAN58
What are your thoughts on PAA now being the lowest valued Phase II Oncology company on the ASX?
Our nearest comparative is $100m MC for an Oncology company IPO last year that have just completed Phase I.
Any insight would be welcomed on why you believe PAA is valued at only $30m?
As you know I'm across 18 to 23 Biotechs at any one time ,, I believe in the Science of MPL for reference ,, I am becoming concerned at the lengthy timeframes and lack of clear communication... especially the timeframe on the Leiden Data 10 months? Before Christmas was the first timeframe ,, now 10 months in surely must impact PAA timeline ,, or there was some serious redundancy added.....
I'm looking at attending the AGM this year and look forward to meeting with you.. NZT
Thank you for your post @RAN58What are your thoughts on PAA now...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.010(5.26%) |
Mkt cap ! $98.34M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 19.5¢ | $116.8K | 582.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61954 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 72033 | 3 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |